ARCHIVES

FDA News: ODAC Recommends Taxol For KS; Votes Against 2 Other Drugs

This article is from The Cancer Letter archive.

Vol. 23 No. 26 | July 4, 1997

Download PDF Visit The Full Archive

Related Articles

NCI To Fund 22 Of 38 Clinical Investigator Applications, Five Of Them To Surgeons

June 1, 1984

Oral Combination Provides Alternative To IV Chemo For Multiple Myeloma

November 29, 2002

Seer Gets Concept Approval For Three More Years, With Several Changes

June 19, 1981

CMS To Recognize NCCN’s Drug Compendium.

June 6, 2008

In Brief: NBCC Honors D’Amato, Leahy, Mack, Stevens; Center Development Officers Elect Leaders

May 8, 1998

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

January 28, 2005